Safety Study of Combined Immunotherapy With Trastuzumab and Cetuximab in Patients With Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Clinical Trials Related to Cetuximab
Related studies linked through entity extraction aliases.
A Phase II Study of Cetuximab Plus Irinotecan in Patients With EGFR-detectable Metastatic Colorectal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Cetuximab With and Without Weekly Paclitaxel for Patients With Previously Treated Advanced Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan and Cetuximab for Colorectal Cancer as Second Line Therapy
- Status
- COMPLETED
- Phase
- PHASE2
CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver Metastases
- Status
- TERMINATED
- Phase
- PHASE4
Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
BAY 43-9006 Plus Cetuximab to Treat Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without Bevacizumab
- Status
- TERMINATED
- Phase
- PHASE2
Study of Albumin Bound-Paclitaxel for Treatment of Recurrent or Metastatic Head and Neck Cancer With Cetuximab
- Status
- TERMINATED
- Phase
- PHASE2
Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Vaccine Therapy, Cyclophosphamide, and Cetuximab in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2